Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus

被引:5
|
作者
Hu, Zili [1 ,2 ]
Yang, Zhenyun [1 ,2 ]
Wang, Jiongliang [1 ,2 ]
Fu, Yizhen [1 ,2 ]
Hu, Zhiwen [1 ,2 ]
Zhou, Zhongguo [1 ,2 ]
Chen, Minshan [1 ,2 ]
Zhang, Yaojun [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, Dept Liver Surg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China
关键词
HCC; hepatocellular carcinoma; PVTT; portal vein tumor thrombus; HAIC; neoadjuvant hepatic arterial infusion chemotherapy; hepatoectomy; neoadjuvant therapy; C-REACTIVE PROTEIN; PHASE-II TRIAL; TRANSARTERIAL CHEMOEMBOLIZATION; CISPLATIN; LIVER; RADIOEMBOLIZATION; SORAFENIB; RESECTION; EFFICACY; SAFETY;
D O I
10.3389/fphar.2023.1223632
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background/purpose: The prognosis of hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT) is generally poor and hepatectomy is optional for these patients. This study aims to explore the survival benefits of neoadjuvant hepatic arterial infusion chemotherapy (HAIC) for resectable HCC with PVTT.Methods: This retrospective study included 120 resectable HCC patients with PVTT who underwent hepatectomy, from January 2017 to January 2021 at Sun Yat-sen University Cancer Center. Of these patients, the overall survival (OS) and recurrence-free survival (RFS) of 55 patients who received hepatectomy alone (Surgery group) and 65 patients who received neoadjuvant HAIC followed by hepatectomy (HAIC-Surgery group) were compared. Logistic regression analysis was conducted to develop a model predicting the response to neoadjuvant HAIC.Results: The OS rates for the HAIC-Surgery group at 1, 3, and 5 years were 94.9%, 78%, and 66.4%, respectively, compared with 84.6%, 47.6%, and 37.2% in the Surgery group (p < 0.001). The RFS rates were 88.7%, 56.2%, and 38.6% versus 84.9%, 38.3%, and 22.6% (p = 0.002). The subgroup analysis revealed that the survival benefit of neoadjuvant HAIC was limited to patients who responded to it. The logistic model, consisting of AFP and CRP, that predicted the response to neoadjuvant HAIC performed well, with an area under the ROC curve (AUC) of 0.756.Conclusion: Neoadjuvant HAIC followed by hepatectomy is associated with a longer survival outcome than hepatectomy alone for HCC patients with PVTT and the survival benefit is limited to patients who respond to neoadjuvant FOLFOX-HAIC.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Sorafenib and Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
    Nagai, Hidenari
    Mukozu, Takanori
    Ogino, Yu
    Matsui, Daigo
    Matsui, Teppei
    Wakui, Noritaka
    Momiyama, Koichi
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    Higai, Koji
    ANTICANCER RESEARCH, 2015, 35 (04) : 2269 - 2277
  • [2] Survival benefit in hepatocellular carcinoma patients with portal vein tumor thrombosis treated by hepatic arterial infusion chemotherapy
    Ando, E
    Tanaka, M
    Yamashita, F
    Kuromatsu, R
    Sumie, S
    Fukumori, K
    Yutani, S
    Yano, Y
    Kumashiro, R
    Sata, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 76 - 77
  • [3] Hepatic Arterial Infusion Chemotherapy: A Potential Therapeutic Option for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
    Moriguchi, Michihisa
    Aramaki, Takeshi
    Tanaka, Toshihiro
    Itoh, Yoshito
    LIVER CANCER, 2018, 7 (02) : 209 - 210
  • [4] Hepatic Arterial Infusion Chemotherapy Followed by Lipiodol Infusion for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Single-Center Experience
    Chen, Kuan-Ting
    Tsai, Kun-Feng
    Leung, Henry W. C.
    Chan, Agnes L. F.
    Wang, Shyh-Yau
    Liang, Huei-Lung
    Tang, Sheng-Yeh
    Chou, Chu-Kuang
    Chen, Hsin-Yu
    Chan, Shan-Ho
    Li, Ming-Feng
    MEDICINA-LITHUANIA, 2021, 57 (08):
  • [5] REDUCTION OF INTRAHEPATIC TUMOR BY HEPATIC ARTERIAL INFUSION CHEMOTHERAPY PROLONGS SURVIVAL IN HEPATOCELLULAR CARCINOMA WITH PORTAL VEIN TUMOR THROMBUS OR DISTANT METASTASIS
    Sung, Pil Soo
    Nam, Heechul
    Bae, Si Hyun
    Yang, Hyun
    HEPATOLOGY, 2019, 70 : 243A - 243A
  • [6] Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis
    Song, Do Seon
    Bae, Si Hyun
    Song, Myeong Jun
    Lee, Sung Won
    Kim, Hee Yeon
    Lee, Young Joon
    Oh, Jung Suk
    Chun, Ho Jong
    Lee, Hae Giu
    Choi, Jong Young
    Yoon, Seung Kew
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (29) : 4679 - 4688
  • [7] Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis
    Do Seon Song
    Si Hyun Bae
    Myeong Jun Song
    Sung Won Lee
    Hee Yeon Kim
    Young Joon Lee
    Jung Suk Oh
    Ho Jong Chun
    Hae Giu Lee
    Jong Young Choi
    Seung Kew Yoon
    World Journal of Gastroenterology, 2013, 19 (29) : 4679 - 4688
  • [8] Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis
    Yung-Chih Lai
    Cheng-Yen Shih
    Chin-Ming Jeng
    Sien-Sing Yang
    Jui-Ting Hu
    Yung-Chuan Sung
    Han-Ting Liu
    Shaw-Min Hou
    Chi-Hwa Wu
    Tzen-Kwan Chen
    World Journal of Gastroenterology, 2003, 9 (12) : 2666 - 2670
  • [9] Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis
    Lai, YC
    Shih, CY
    Jeng, CM
    Yang, SS
    Hu, JT
    Sung, YC
    Liu, HT
    Hou, SM
    Wu, CH
    Chen, TK
    WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (12) : 2666 - 2670
  • [10] Hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus
    Toshiya Kamiyama
    Tatsuhiko Kakisaka
    Tatsuya Orimo
    Kenji Wakayama
    World Journal of Hepatology, 2017, (36) : 1296 - 1304